Search results for "Irritable Bowel Syndrome"

showing 10 items of 80 documents

Low Prevalence of Celiac Disease among Patients with Functional Gastrointestinal Disorders in Latvia.

2020

Background and Aims: Studies suggest that the prevalence of celiac disease (CD) is increased in individuals with functional gastrointestinal disorders (FGIDs), in particular, irritable bowel syndrome (IBS); however, the evidence is conflicting. We aimed to analyze the prevalence of CD in patients with FGIDs in Latvia.
 Methods: This retrospective study included patients with FGIDs, referred for a gastroenterologist consultation in a secondary gastroenterology practice unit. Patients were divided into three groups – patients only with IBS (IBS group), patients only with functional dyspepsia (FD) (FD group), patients with mixed symptoms IBS and FD (Mixed group). Patient levels of tissue …

Malemedicine.medical_specialtyGastrointestinal DiseasesDiseaseGastroenterologySerologyIrritable Bowel SyndromeGTP-Binding ProteinsInternal medicineBiopsymedicinePrevalenceHumansMixed groupIn patientProtein Glutamine gamma Glutamyltransferase 2Serologic TestsDuodenoscopyIrritable bowel syndromeAutoantibodiesRetrospective StudiesRoutine screeningTransglutaminasesmedicine.diagnostic_testbusiness.industryGastroenterologyRetrospective cohort studyMiddle Agedmedicine.diseaseLatviaImmunoglobulin ACeliac DiseaseFemaleSymptom AssessmentbusinessJournal of gastrointestinal and liver diseases : JGLD
researchProduct

Response to Villanacci et al.

2013

REFERENCES 1 . Carroccio A , Mansueto P , Iacono G et al. Nonceliac wheat sensitivity diagnosed by doubleblind placebo-controlled challenge: exploring a new clinical entity . Am J Gastroenterol 2013 (this issue) . 2 . Ludvigsson JF , Le$ er DA , Bai JC et al. " e Oslo de! nitions for coeliac disease and related terms . Gut 2013 ; 62 : 43 – 52 . 3 . Sapone A , Bai JC , Ciacci C et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classi! cation . BMC Med 2012 ; 10 – 13 . 4 . Ferch CC , Chey WD . Irritable bowel syndrome and gluten sensitivity without celiac disease: separating the wheat from the cha% . Gastroenterology 2012 ; 142 : 664 – 6 . 5 . Biesiekierski JR , N…

Malemedicine.medical_specialtyPathologySettore MED/09 - Medicina InternaHepatologybusiness.industryNon-celiac gluten sensitivityGastroenterologyGluten sensitivitymedicine.diseaseGastroenterologyCoeliac diseaseGliadinInternal medicineMedicineHumansFemalebusinessNon-celiac gluten sensitivityIrritable bowel syndromeFood HypersensitivityTriticumAutoantibodies
researchProduct

Non-celiac wheat sensitivity is a more appropriate label than non-celiac gluten sensitivity.

2013

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaNon-celiac wheat sensitivity; non-celiac gluten sensitivityHepatologyGlutensNon-celiac wheat sensitivitybusiness.industrynon-celiac gluten sensitivityGastroenterologymedicine.diseaseGastroenterologyIrritable Bowel SyndromeDiet Gluten-FreeInternal medicineMedicineHumansGluten freeFemaleSensitivity (control systems)businessNon-celiac gluten sensitivityIrritable bowel syndromeGastroenterology
researchProduct

POSSIBLE RELATION BETWEEN GUT MICROFLORA COMPOSITION AND ONCOGENIC RISK: IS STIMULATION OF INFLAMMATION THE ONE RING OF CONNECTION?

2012

Human intestinalmicrobiotais characterizedby highpopulationdensity, wide diversity and complexity of interactions. Dysbiosis, both qualitative and quantitative, might have serious health consequences including an increase in the number and/or alteration of bacteria colonizing the gastrointestinal tract, which could be referred as gut microflora imbalance (GMI). GMI is frequently found in patients suffering from irritable bowel syndrome; this is the reason why some authors believe that IBS is secondary to GMI. Interestingly, GMI is also found in about 25% of Crohn’s disease patients. Stimulation of inflammation by the ‘dangerous bacteria’, through specific activation of the intestinal immune…

Microbiology (medical)Gastrointestinal tractSettore MED/09 - Medicina InternaInflammationStimulationDiseaseBiologymedicine.diseaseCHRONIC INFLAMMATORY INTESTINAL DISEASES COLORECTAL CANCER COMMENSAL BACTERIA METABOLISM GUT MICROFLORA INTESTINAL STEM CELLS.Settore MED/18 - Chirurgia GeneraleImmune systemImmunologymedicinemedicine.symptomStem cellDysbiosisIrritable bowel syndrome
researchProduct

Non-Celiac Wheat Sensitivity Diagnosed by Double-Blind Placebo-Controlled Challenge: Exploring a New Clinical Entity.

2012

Non-Celiac Wheat Sensitivity Diagnosed by Double-Blind Placebo-Controlled Challenge: Exploring a New Clinical Entity

Non-Celiac Wheat SensitivityPediatricsmedicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryNon-celiac gluten sensitivityGastroenterologyDouble-Blind Placebo-Controlled Challengenutritional and metabolic diseasesfood and beveragesmedicine.diseasePlaceboFood hypersensitivitydigestive system diseasesDouble blindNon-Celiac Wheat Sensitivity; Double-Blind Placebo-Controlled Challenge;Severity of illnessmedicineDifferential diagnosisbusinessNon-celiac gluten sensitivityIrritable bowel syndromeWheat allergy
researchProduct

Duodenal and Rectal Mucosa Inflammation in Patients With Non-celiac Wheat Sensitivity

2019

Background & Aims: Studies of non-celiac gluten or wheat sensitivity (NCGWS) have increased but there are no biomarkers of this disorder. We aimed to evaluate histologic features of colon and rectal tissues from patients with NCGWS. Methods: We performed a prospective study of 78 patients (66 female; mean age, 36.4 years) diagnosed with NCGWS by double-blind wheat challenge at 2 tertiary care centers in Italy, from January 2015 through September 2016. Data were also collected from 55 patients wither either celiac disease or self-reported NCGWS but negative results from the wheat-challenge test (non-NCGWS controls). Duodenal and rectal biopsies were collected and analyzed by immunohistoc…

Pathologymedicine.medical_specialtyHistologySettore MED/09 - Medicina InternaNonceliac Wheat SensitivityInflammationIrritable Bowel SyndromePathogenesis03 medical and health sciences0302 clinical medicinemedicineIrritable bowel syndromeLamina propriaHepatologybusiness.industryGastroenterologyHistologyBreadmedicine.diseaseFood Allergymedicine.anatomical_structure030220 oncology & carcinogenesisImmunohistochemistryIntraepithelial lymphocyte030211 gastroenterology & hepatologymedicine.symptombusinessCD8Clinical Gastroenterology and Hepatology
researchProduct

INFLAMMATION IN IRRITABLE BOWEL SYNDROME: MYTH OR NEW TREATMENT TARGET?

2016

Low-grade intestinal inflammation plays a key role in the pathophysiology of irritable bowel syndrome (IBS), and this role is likely to be multifactorial. The aim of this review was to summarize the evidence on the spectrum of mucosal inflammation in IBS, highlighting the relationship of this inflammation to the pathophysiology of IBS and its connection to clinical practice. We carried out a bibliographic search in Medline and the Cochrane Library for the period of January 1966 to December 2014, focusing on publications describing an interaction between inflammation and IBS. Several evidences demonstrate microscopic and molecular abnormalities in IBS patients. Understanding the mechanisms u…

Pathologymedicine.medical_specialtyMEDLINEAnti-Inflammatory AgentsInflammationCochrane LibraryBioinformaticsMast cell03 medical and health sciences0302 clinical medicineTreatment targetsGastrointestinal AgentsIntestinal inflammationmedicinePathologyAnimalsHumansMolecular Targeted TherapyTopic HighlightIntestinal MucosaIrritable bowel syndromeInflammationSettore MED/12 - GastroenterologiaMechanism (biology)business.industrySettore BIO/16 - Anatomia UmanaGastroenterologyGeneral MedicineInflammation; Irritable bowel syndrome; Mast cells; Neuroendocrine cells; Pathologymedicine.diseaseEnteritisClinical trialIrritable bowel syndromeSettore MED/18 - Chirurgia Generale030220 oncology & carcinogenesisNeuroendocrine cell030211 gastroenterology & hepatologymedicine.symptomInflammation Mediatorsbusiness
researchProduct

Personality and fatigue perception in a sample of IBD outpatients in remission: a preliminary study.

2012

International audience; BACKGROUND AND AIMS: Fatigue is considered as a feature of IBD. Nevertheless, medical variables would partly explain this complex phenomenon. Psychological variables would be especially connected to fatigue for patients in remission. Moreover, personality is known to be linked to the fatigue of patients with CFS. This preliminary study aimed to determine if personality dimensions are linked to the perception of fatigue in IBD. METHODS: 81 IBD outpatients in remission completed the MFI (fatigue); ISI, EES (sleep disturbances); TCI-R (personality); HADS (depression and anxiety). Medical data were collected (ferritin, C-reactive protein, number of flare-ups, number of h…

Persistence (psychology)AdultMalemedicine.medical_specialtymedia_common.quotation_subjectIBDAnxietyPersonality DisordersSeverity of Illness Index03 medical and health sciences0302 clinical medicineQuality of life[ CHIM.ORGA ] Chemical Sciences/Organic chemistrySeverity of illnessOutpatientsmedicinePersonalityHumansPsychiatryIrritable bowel syndromeDepression (differential diagnoses)Fatiguemedia_commonRetrospective Studiesbusiness.industryDepression[CHIM.ORGA]Chemical Sciences/Organic chemistryGastroenterologyRetrospective cohort studySleep disturbancesGeneral Medicinemedicine.diseaseInflammatory Bowel Diseases030227 psychiatry3. Good healthQuality of LifeAnxiety030211 gastroenterology & hepatologyFemalePerceptionmedicine.symptombusinessFollow-Up StudiesPersonalityJournal of Crohn'scolitis
researchProduct

A MIXTURE OF VEGETABLE EXTRACTS (CHAMOMILLE, PASSIONFLOWER, CARAWAY, FENNEL), AND ENZYMES (BETA-GALACTOSIDASE) FOR IRRITABLE BOWEL SYNDROME (ibs): AN…

2018

Summary. Aims: Irritable bowel syndrome (IBS) is a functional intestinal disorder. This syndrome may creates psychological disorders in patients who are affected and severely limits daily activities and lifestyle. Methods: We investigated the effect of the natural product consisting of chamomile, fennel, caraway, passionflower and melissa (Spasmicol®), on IBS patients. For the study, 187 patients with IBS, enrolled by primary care doctors, were treated with Spasmicol® (Aristeia Farmaceutici s.r.l.), two tablets/daily, for 30 days. At the end of the study, patients were re-evaluated to analyse the effects of therapy. Results: After 30 days, patients showed a marked reduction of symptoms (abd…

Settore MED/12 - GastroenterologiaSettore MED/18 - Chirurgia GeneraleIrritable Bowel Syndrome supplements alternative supplements colitisSettore BIO/16 - Anatomia Umana
researchProduct

Cognitive behavior therapy for functional gastrointestinal disorders: is group treatment effective?

2003

Objective:The intention of this study was to evaluate therapy outcome of a cognitive-behavioral group treatment program for functional gastrointestinal disorders. As a particular characteristic, gastrointestinal symptoms were investigated independently from diagnostic categories on a dimensional basis, considering the persistence of symptoms as well as the aspect of severity.Methods:A total of 64 subjects participated in the 10-week treatment program, and 49 completed the study. Subjects underwent four assessments (baseline, pre-, post-treatment, 12-month follow-up), each comprising several self-rated questionnaires on gastrointestinal, somatoform, depressive, hypochondriacal and anxious sy…

Therapy OutcomeComorbid psychopathologymedicine.medical_specialtybusiness.industryTreatment outcomeDiagnostic interviewCognitionmedicine.diseaseGroup treatmentPsychiatry and Mental healthLocus of controlInternal medicinePhysical therapyMedicinebusinessBiological PsychiatryIrritable bowel syndromeActa Neuropsychiatrica
researchProduct